General Information of the Compound
| Compound ID |
CP0172611
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3R,5R)-adamantan-1-yl(pyrrolidin-1-yl)methanone
Show/Hide
|
||||||||||||||||||
| Synonyms |
(3r,5r,7r)-adamantan-1-yl(pyrrolidin-1-yl)methanone
1-(adamantane-1-carbonyl)pyrrolidine
1-adamantyl(1-pyrrolidinyl)methanone
1-adamantyl(pyrrolidin-1-yl)methanone
22508-51-6
AC1MCDV9
AKOS000612243
Adamantan-1-yl-pyrrolidin-1-yl-methanone
BDBM50207788
CB09819
CBMicro_007397
CCG-246226
CHEMBL392866
Cambridge id 5142982
HMS1608M03
HMS2477C05
MCULE-7009966643
MLS000526196
MolPort-001-930-821
Oprea1_111627
Oprea1_295021
SCHEMBL3456185
SMSF0003738
STK091400
ZINC4031845
adamantanyl pyrrolidinyl ketone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H23NO
|
||||||||||||||||||
| Molecular Weight |
233.355
|
||||||||||||||||||
| Canonical SMILES |
O=C(N1CCCC1)C12CC3CC(CC(C3)C1)C2
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H23NO/c17-14(16-3-1-2-4-16)15-8-11-5-12(9-15)7-13(6-11)10-15/h11-13H,1-10H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
RVXVNLMWQYKNHL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound